Director of Technology Development, i2O Therapeutics

Dr. Tyler Brown received his PhD from Harvard University in bioengineering and has 10+ years of experience designing and leading collaborative projects in drug delivery and materials science. Dr. Brown has a passion for bridging the gaps between basic scientific research and the commercialization of technologies. He previously led business development teams specializing in early-stage technology commercialization though the Harvard Office of Technology Development. He co-led the Healthcare Innovation and Commercialization Course at Harvard Medical School in 2018 and was actively involved in the Harvard Biotech Club and Harvard Innovation Labs. He also holds a graduate certificate in management practice and an MS in biochemistry and molecular biology from the University of California, Santa Barbara.

Co-Founder and Chief Product Officer of Cellino Biotec

Marinna is a co-founder at Cellino, a venture capital-backed biotech company building the next generation of cell-based tissues and therapies with a proprietary platform technology. She received her PhD and MA in Applied Physics from Harvard University, where she co-invented laser-based intracellular delivery techniques. She received her BSc in Biophysics from University of California, Los Angeles, after transferring from Riverside Community College. She is the recipient of the Harvard Graduate Prize Fellowship, the Catalyst Accelerator Grant from Harvard Medical School, and is on the Forbes 30 Under 30 2019 list for Healthcare. She has several patents, peer-reviewed publications, and wrote the first review paper on autologous iPSC-based cell therapies.